GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » Margin of Safety % (DCF Earnings Based)

Taro Pharmaceutical Industries (FRA:TAL) Margin of Safety % (DCF Earnings Based) : N/A (As of May. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Taro Pharmaceutical Industries's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


Competitive Comparison of Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based) falls into.



Taro Pharmaceutical Industries Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (FRA:TAL) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Taro Pharmaceutical Industries (FRA:TAL) Headlines

From GuruFocus

TAL Education Group: Company Investigated by the Portnoy Law Firm

By sperokesalga sperokesalga 05-29-2023

TAL Education Group Files Its Annual Report on Form 20-F

By PRNewswire PRNewswire 05-31-2023